S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Eco Animal Health GroupMedical Developments InternationalBEXIMCO PHARMAC/S GDR REGSTrilogy International PartnersAllergy Therapeutics
SymbolLON:EAHASX:MVPLON:BXPTSE:TRLLON:AGY
Price Information
Current PriceGBX 340A$5.79GBX 34.70C$1.97GBX 11.75
52 Week RangeBuyN/AN/ABuyBuy
Analyst Ratings
Consensus RecommendationBuyN/AN/ABuyBuy
Consensus Price TargetGBX 600N/AN/AC$3.50GBX 37.50
% Upside from Price Target76.47% upsideN/AN/A77.66% upside219.15% upside
Trade Information
Market Cap£224.97 million$379.34 million£139.88 millionC$116.63 million£73.16 million
BetaN/AN/AN/AN/AN/A
Average Volume39,512N/A35,55538,105167,682
Sales & Book Value
Annual Revenue£74.58 million$20.88 millionN/AC$764.72 million£73.72 million
Price / Sales3.0818.17N/A0.151.01
CashflowGBX 26.80 per shareA$0.44 per shareN/AC$1.50 per shareGBX 4.30 per share
Price / Cash12.6913.22N/A1.312.73
Book ValueGBX 159.30 per shareA$0.68 per shareN/AC($1.39) per shareGBX 5.90 per share
Price / Book0.028.50N/A-1.420.02
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSGBX 17.30A$0.02N/AC($0.51)GBX 0.50
Trailing P/E Ratio19.65361.880.00N/A23.50
Forward P/E Ratio
P/E GrowthN/AN/AN/AC($29.67)N/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutGBX 0.15A$0.04GBX 0.01C$0.01N/A
Dividend Yield0.04%0.69%0.03%0.75%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout Ratio0.87%250.00%N/AN/A N/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.76%0.41%38.08%N/A6.49%
Current Ratio4.09%4.21%1.17%1.12%2.77%
Quick Ratio3.04%3.81%0.36%0.85%2.21%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees207554,2001,821500
Shares Outstanding67.52 million65.52 million405.56 million58.02 million636.17 million
Next Earnings DateN/AN/AN/A11/6/2019 (Confirmed)N/A
OptionableNot OptionableNot OptionableOptionableNot OptionableNot Optionable
 Eco Animal Health GroupMedical Developments InternationalBEXIMCO PHARMAC/S GDR REGSTrilogy International PartnersAllergy Therapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel